The DOI matches its Crossref record; 39 of the 44 references it cites were found in a registry or an index.
Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial
Open accessAbstract
Importance: In one-third of older men with anemia, no recognized cause can be found. Objective: To determine if testosterone treatment of men 65 years or older with unequivocally low testosterone levels and unexplained anemia would increase their hemoglobin concentration. Design, Setting, and Participants: A double-blinded, placebo-controlled trial with treatment allocation by minimization using 788 men 65 years or older who have average testosterone levels of less than 275 ng/dL. Of 788 participants, 126 were anemic (hemoglobin ≤12.7 g/dL), 62 of whom had no known cause. The trial was conducted in 12 academic medical centers in the United States from June 2010 to June 2014. Interventions: Testosterone gel, the dose adjusted to maintain the testosterone levels normal for young men, or placebo gel for 12 months. Main Outcomes and Measures: The percent of men with unexplained anemia whose hemoglobin levels increased by 1.0 g/dL or more in response to testosterone compared with placebo. The statistical analysis was intent-to-treat by a logistic mixed effects model adjusted for balancing factors. Results: The men had a mean age of 74.8 years and body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) of 30.7; 84.9% were white. Testosterone treatment resulted in a greater percentage of men with unexplained anemia whose month 12 hemoglobin levels had increased by 1.0 g/dL or more over baseline (54%) than did placebo (15%) (adjusted OR, 31.5; 95% CI, 3.7-277.8; P = .002) and a greater percentage of men who at month 12 were no longer anemic (58.3%) compared with placebo (22.2%) (adjusted OR, 17.0; 95% CI, 2.8-104.0; P = .002). Testosterone treatment also resulted in a greater percentage of men with anemia of known cause whose month 12 hemoglobin levels had increased by 1.0 g/dL or more (52%) than did placebo (19%) (adjusted OR, 8.2; 95% CI, 2.1-31.9; P = .003). Testosterone treatment resulted in a hemoglobin concentration of more than 17.5 g/dL in 6 men who had not been anemic at baseline. Conclusions and Relevance: Among older men with low testosterone levels, testosterone treatment significantly increased the hemoglobin levels of those with unexplained anemia as well as those with anemia from known causes. These increases may be of clinical value, as suggested by the magnitude of the changes and the correction of anemia in most men, but the overall health benefits remain to be established. Measurement of testosterone levels might be considered in men 65 years or older who have unexplained anemia and symptoms of low testosterone levels. Trial Registration: clinicaltrials.gov Identifier: NCT00799617.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A meta-analysis of the literature suggests that men who have a history of unexplained anemia, 7 bone density loss, 8 diabetes, 9 exposure to chemotherapy, 10 direct or scatter radiation therapy to the testes, 11 HIV, 12 a history of chronic narcotic use, 13 infertility, 14 pituitary disorders, 15 and chronic corticosteroid use 16 are at risk for low testosterone.”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“10% of LSM induced weight loss with 2.9 nmol/L increase of total testosterone”
From Effects of liraglutide on obesity-associated functional hypogonadism in men (2019) · cites this paper as [21]
In the citing paper
“Five per cent of weight loss with LSM was associated with the 2 mmol/L increase of total testosterone and no increase of free testosterone (21)”
From Effects of liraglutide on obesity-associated functional hypogonadism in men (2019) · cites this paper as [21]
In the citing paper
“weight loss of more than 15% with increase by 5.7 mmol/L (21)”
From Effects of liraglutide on obesity-associated functional hypogonadism in men (2019) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Self-citationFeldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004) · Blood · doi:10.1182/blood-2004-05-1812 · Cited by 1,450
Redelmeier, D. A., Bayoumi, A. M., Goldstein, R. S., & Guyatt, G. H. (1997) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.155.4.9105067 · Cited by 1,029
The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?
Beutler, E., & Waalen, J. (2005) · Blood · doi:10.1182/blood-2005-07-3046 · Cited by 971
Effects of Testosterone Treatment in Older Men
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506119 · Cited by 890
Self-citationWang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656
Self-citationEffects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 610
Self-citation
Cited by
Sorted by citations
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
Self-citationEvaluation and Management of Testosterone Deficiency: AUA Guideline
Mulhall, J. P., Trost, L. W., Brannigan, R. E., Kurtz, E. G., Redmon, J. B., Chiles, K. A., Lightner, D. J., Miner, M. M., Murad, M. H., Nelson, C. J., et al. (2018) · Journal of Urology · doi:10.1016/j.juro.2018.03.115 · Cited by 766
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00020 · Cited by 594
Cardiovascular Safety of Testosterone-Replacement Therapy
Lincoff, A. M., Bhasin, S., Flevaris, P., Mitchell, L. M., Basaria, S. S., Boden, W. E., Cunningham, G. R., Granger, C. B., Khera, M., Thompson, I. M., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2215025 · Cited by 514
Self-citationPaediatric and adult-onset male hypogonadism
Salonia, A., Rastrelli, G., Hackett, G., Seminara, S. B., Huhtaniemi, I. T., Rey, R. A., Hellstrom, W. J. G., Palmert, M. R., Corona, G., Dohle, G. R., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0087-y · Cited by 286
Lessons From the Testosterone Trials
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., et al. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00234 · Cited by 280
Self-citationFrailty and the endocrine system
Clegg, A. P., & Hassan-Smith, Z. K. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30110-4 · Cited by 278
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
Swerdloff, R. S., Dudley, R. E., Page, S. T., Wang, C., & Salameh, W. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1067 · Cited by 260
Self-citationTestosterone replacement therapy and cardiovascular risk
Gagliano‐Jucá, T., & Basaria, S. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0211-4 · Cited by 200
Self-citationPonce, O. J., Spencer-Bonilla, G., Alvarez-Villalobos, N., Serrano, V., Singh-Ospina, N., Rodriguez-Gutierrez, R., Salcido-Montenegro, A., Benkhadra, R., Prokop, L. J., Bhasin, S., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00404 · Cited by 148
Self-citationAging and the Male Reproductive System
Kaufman, J., Lapauw, B., Mahmoud, A., T'Sjoen, G. G., & Huhtaniemi, I. T. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00178 · Cited by 150
Hackett, G. I., Kirby, M. G., Edwards, D., Jones, T. H., Wylie, K. R., Ossei‐Gerning, N., David, J., & Muneer, A. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.10.067 · Cited by 151
Testosterone Treatment and Fractures in Men with Hypogonadism
Snyder, P. J., Bauer, D. C., Ellenberg, S. S., Cauley, J. A., Buhr, K. A., Bhasin, S., Miller, M. G., Khan, N., Li, X., & Nissen, S. E. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2308836 · Cited by 147
Self-citationStellingwerff, T., Peeling, P., Garvican‐Lewis, L. A., Hall, R. C., Koivisto, A., Heikura, I. A., & Burke, L. M. (2019) · Sports Medicine · doi:10.1007/s40279-019-01159-w · Cited by 136
Girelli, D., Marchi, G., & Camaschella, C. (2018) · HemaSphere · doi:10.1097/hs9.0000000000000040 · Cited by 137
Effects of liraglutide on obesity-associated functional hypogonadism in men
Jensterle, M., Podbregar, A., Goricar, K., Gregoric, N., & Janez, A. (2019) · Endocrine Connections · doi:10.1530/ec-18-0514 · Cited by 101
Handelsman, D. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab001 · Cited by 104
Hackett, G. I., Kirby, M. G., Rees, R. W., Jones, T. H., Muneer, A., Livingston, M. A., Ossei‐Gerning, N., David, J., Foster, J., Kalra, P. A., et al. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.221027 · Cited by 99
Testosterone replacement therapy: for whom, when and how?
Tsametis, C. P., & Isidori, A. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.007 · Cited by 96
Bhasin, S., Lincoff, A. M., Basaria, S. S., Bauer, D. C., Boden, W. E., Cunningham, G. R., Davey, D. A., Dubcenco, E., Fukumoto, S., Garcia, M., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.11.016 · Cited by 88
Self-citationTestosterone therapy and venous thromboembolism: A systematic review and meta-analysis
Houghton, D. E., Alsawas, M., Barrioneuvo, P., Tello, M., Farah, W. H., Beuschel, B., Prokop, L. J., Layton, J. B., Murad, M. H., & Moll, S. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.10.023 · Cited by 84
Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review
Dandona, P., Dhindsa, S., Ghanim, H., & Saad, F. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14206 · Cited by 90
Iron status in the elderly: A review of recent evidence
Wawer, A. A., Jennings, A., & Fairweather‐Tait, S. J. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.003 · Cited by 77
Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism
Kezele, T. G., & Ćurko‐Cofek, B. (2020) · Nutrients · doi:10.3390/nu12092601 · Cited by 78
Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
Mohammadi‐Shemirani, P., Chong, M., Pigeyre, M., Morton, R. W., Gerstein, H. C., & Paré, G. (2020) · eLife · doi:10.7554/elife.58914 · Cited by 70
Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism
Pencina, K. M., Travison, T. G., Artz, A. S., Lincoff, A. M., Nissen, S. E., Flevaris, P., Chan, A., Li, X., Diegel, S. A., Wannemuehler, K. A., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.40030 · Cited by 69
Self-citationHauger, R. L., Saelzler, U. G., Pagadala, M. S., & Panizzon, M. S. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09767-0 · Cited by 68
Morgentaler, A., Traish, A. M., Hackett, G. I., Jones, T. H., & Ramasamy, R. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.06.003 · Cited by 67
Unexplained anemia of aging: Etiology, health consequences, and diagnostic criteria
Guralnik, J. M., Ershler, W. B., Artz, A. S., Lazo‐Langner, A., Walston, J. D., Pahor, M., Ferrucci, L., & Evans, W. J. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17565 · Cited by 63
Self-citationMale hypogonadism: pathogenesis, diagnosis, and management
de Silva, N. L., Papanikolaou, N., Grossmann, M., Antonio, L., Quinton, R., Anawalt, B. D., & Jayasena, C. N. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00199-2 · Cited by 68
Anabolic-Androgenic Steroid Use in Sports, Health, and Society
Bhasin, S., Hatfield, D. L., Hoffman, J. R., Kraemer, W. J., LaBotz, M., Phillips, S. M., & Ratamess, N. A. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002670 · Cited by 63
Self-citationSteeg, L. G. V., Dhakal, S., Woldetsadik, Y. A., Park, H.-S., Mulka, K. R., Reilly, E. C., Topham, D. J., & Klein, S. L. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008506 · Cited by 54
Testosterone Therapy: Review of Clinical Applications.
Petering, R. C., & Brooks, N. A. (2017) · PubMed · Cited by 51
Testosterone, cognitive decline and dementia in ageing men
Yeap, B. B., & Flicker, L. A. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09728-7 · Cited by 51
Traish, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_22 · Cited by 50
Haematological actions of androgens
Warren, A. M., & Grossmann, M. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101653 · Cited by 59
Genetic analyses implicate complex links between adult testosterone levels and health and disease
Leinonen, J. T., Mars, N., Lehtonen, L. E., Ahola‐Olli, A., Ruotsalainen, S., Lehtimäki, T. J., Kähönen, M. A. P., Raitakari, O. T., Mars, N., Ruotsalainen, S., et al. (2023) · Communications Medicine · doi:10.1038/s43856-022-00226-0 · Cited by 46
Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.10.001 · Cited by 46
Yeap, B. B., Page, S. T., & Grossmann, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30416-3 · Cited by 43
Handelsman, D. J. (2017) · JAMA · doi:10.1001/jama.2017.0129 · Cited by 42
Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
Glueck, C. J., Goldenberg, N., & Wang, P. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm8010011 · Cited by 41
Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank
Watts, E. L., Perez‐Cornago, A., Kothari, J., Allen, N. E., Travis, R. C., & Key, T. J. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1525 · Cited by 41
Gagliano‐Jucá, T., Pencina, K. M., Guo, W., Li, Z., Huang, G. T.-W., Basaria, S. S., & Bhasin, S. (2020) · Andrology · doi:10.1111/andr.12834 · Cited by 40
Self-citationAnemia in older adults as a geriatric syndrome: A review
Katsumi, A., Abe, A., Tamura, S., & Matsushita, T. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14183 · Cited by 48
Fode, M. M., Salonia, A., Minhas, S., Burnett, A. L. “., & Shindel, A. W. (2019) · European Urology Focus · doi:10.1016/j.euf.2019.02.021 · Cited by 36
Improving clinical outcomes through attention to sex and hormones in research
Mielke, M. M., & Miller, V. M. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00531-z · Cited by 40
Nightingale, T. E., Moore, P. D., Harman, J., Khalil, R. E., Gill, R. S., Castillo, T. A., Adler, R. A., & Gorgey, A. S. (2017) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2017.1357917 · Cited by 37
Gagliano‐Jucá, T., Pencina, K. M., Ganz, T., Travison, T. G., Kantoff, P. W., Nguyen, P. L., Taplin, M., Kibel, A. S., Li, Z., Huang, G. T.-W., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00272.2018 · Cited by 34
Self-citationThe Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
Shin, Y. S., & Park, J. K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020209 · Cited by 34
Prevalência de anemia em adultos e idosos brasileiros
Machado, Í. E., Malta, D. C., Bacal, N. S., & Rosenfeld, L. G. (2019) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-549720190008.supl.2 · Cited by 41
Stephens‐Shields, A. J., Snyder, P. J., Ellenberg, S. S., Taylor, L., & Bhasin, S. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac028 · Cited by 35
Self-citationSesti, F. F., Pofi, R., Minnetti, M., Tenuta, M., Gianfrilli, D., & Isidori, A. M. (2020) · Andrology · doi:10.1111/andr.12876 · Cited by 31
Gadó, K., Khodier, M., Virág, A., Domján, G., & Dörnyei, G. (2022) · Physiology International · doi:10.1556/2060.2022.00218 · Cited by 34
Relation of Testosterone Levels to Mortality in Men With Heart Failure
Yoshihisa, A., Suzuki, S., Sato, Y., Kanno, Y., Abe, S., Miyata, M., Sato, T., Oikawa, M., Kobayashi, A., Yamaki, T., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.052 · Cited by 29
Jasuja, G. K., Ameli, O., Reisman, J. I., Rose, A. J., Miller, D. R., Berlowitz, D. R., & Bhasin, S. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17141 · Cited by 28
Self-citationCunningham, G. R., Ellenberg, S. S., Bhasin, S., Matsumoto, A. M., Parsons, J. K., Preston, P. E., Cauley, J. A., Gill, T. M., Swerdloff, R. S., Wang, C., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00806 · Cited by 28
Self-citationTestosterone Treatment in Middle-Aged and Older Men with Hypogonadism
Bhasin, S., & Snyder, P. J. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2404637 · Cited by 27
Self-citationGrossmann, M., Jayasena, C. N., & Anawalt, B. D. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad180 · Cited by 25
Kaisman‐Elbaz, T., Elbaz, Y., Merkin, V., Dym, L., Noy, A., Vardi, M. Y., Bari, R., Turiel, S., Alt, A., Zamed, T., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00432 · Cited by 23
Miner, M. M., Morgentaler, A., Khera, M., & Traish, A. M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13589 · Cited by 23
Okuno, K., Naito, Y., Asakura, M., Sugahara, M., Ando, T., Yasumura, S., Nagai, T., Saito, Y., Yoshikawa, T., Masuyama, T., et al. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01349-6 · Cited by 23
Androgens and Anemia: Current Trends and Future Prospects
Al‐Sharefi, A., Mohammed, A., Abdalaziz, A., & Jayasena, C. N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00754 · Cited by 26
Jones, T. H., Dobs, A. S., Randeva, H. S., Moore, W., & Parkin, J. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad099 · Cited by 27
The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
Zhang, J., Zhou, X., Ding, H., Wang, L., Liu, S., Liu, Y., & Chen, Z. (2020) · BMC Urology · doi:10.1186/s12894-020-00602-9 · Cited by 22
Marcelli, M., & Mediwala, S. N. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001233 · Cited by 23
Zitzmann, M., Cremers, J. F., Krallmann, C., & Kliesch, S. (2022) · The Aging Male · doi:10.1080/13685538.2022.2063830 · Cited by 20
Bi, H., Huang, Y., Wang, G., Ma, L., & Lu, M. (2019) · Urologia Internationalis · doi:10.1159/000500561 · Cited by 19
Testosterone therapy in older men: clinical implications of recent landmark trials
Grossmann, M., Anawalt, B. D., & Yeap, B. B. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae071 · Cited by 18
Unexplained Anemia in the Elderly
Ershler, W. B. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.03.002 · Cited by 16
Treatment options for anemia in the elderly
Busti, F., Marchi, G., Zidanes, A. L., Castagna, A., & Girelli, D. (2019) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2019.06.018 · Cited by 17
Detection of testosterone microdosing in healthy females
Savkovic, S., Ly, L. P., Desai, R., Howa, J. D., Nair, V. S., Eichner, D., & Handelsman, D. J. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3202 · Cited by 15
Testosterone treatment of late-onset hypogonadism – benefits and risks
Snyder, P. J. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09712-1 · Cited by 15
Self-citationMatsumoto, A. M. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.04.004 · Cited by 15
Self-citationThe role of iron in mediating testosterone's effects on erythropoiesis in mice
Guo, W., Ghayda, R. A., Schmidt, P. J., Fleming, M. D., & Bhasin, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000920rr · Cited by 14
Self-citationThe medicalization of testosterone: reinventing the elixir of life
Gagliano‐Jucá, T., Álvarez, M., & Basaria, S. S. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09751-8 · Cited by 16
Self-citationSymptoms of Late-Onset Hypogonadism in Men
Snyder, P. J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.04.001 · Cited by 14
Self-citationAndrogens as the “old age stick” in skeletal muscle
Gentile, G., Stefano, F. D., Sorrentino, C., D’Angiolo, R., Lauretta, C., Giovannelli, P., Migliaccio, A., Castoria, G., & Donato, M. D. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02163-6 · Cited by 18
Optimizing Diagnostic Accuracy and Treatment Decisions in Men With Testosterone Deficiency
Bhasin, S., & Ozimek, N. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.08.002 · Cited by 15
Self-citationFalqueto, H., dos Santos, M. R., & Manfredi, L. H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.838526 · Cited by 16
Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism
Galbiati, F., Goldman, A. L., Gattu, A. K., Guzelce, E. C., & Bhasin, S. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.011 · Cited by 14
Self-citationTestosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
Pantalone, K. M., George, J., Ji, X., Kattan, M. W., Milinovich, A., Bauman, J. M., Burguera, B. G., Zimmerman, R. S., & Misra‐Hebert, A. D. (2019) · Basic and Clinical Andrology · doi:10.1186/s12610-019-0085-7 · Cited by 14
Gosmanov, A. R., Gemoets, D. E., & Schumacher, K. A. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02350-1 · Cited by 13
Huang, Y., Dong, Y., Zhang, H., Lou, B., Ren, Y., Yao, Y., Dong, M., Donglei, Y., Lv, F., & Chen, Y. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01993-1 · Cited by 13
Artz, A. S., Stephens‐Shields, A. J., Bhasin, S., Ellenberg, S. S., Cohen, H. J., & Snyder, P. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa521 · Cited by 14
Self-citationTherapeutic effects of androgens for cachexia
Giovanelli, L., & Quinton, R. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101598 · Cited by 13
Abildgaard, J., Petersen, J. H., Bang, A. K., Aksglæde, L., Christiansen, P., Juul, A., & Jørgensen, N. (2021) · Andrology · doi:10.1111/andr.13124 · Cited by 13
The Illusory Case for Treatment of an Invented Disease
Handelsman, D. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.682620 · Cited by 12
Figueiredo, M. G., Gagliano‐Jucá, T., & Basaria, S. S. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.12.002 · Cited by 12
Self-citationXu, Y., Cao, W., Shen, Y., Tang, J., Wang, Y., Ma, X., & Bao, Y. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01002-w · Cited by 12
Yeap, B. B., Marriott, R. J., Adams, R., Antonio, L., Ballantyne, C. M., Bhasin, S., Cawthon, P. M., Couper, D. J., Dobs, A. S., Flicker, L. A., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034777 · Cited by 12
Self-citationDeebel, N. A., Matthew, A. N., Loloi, J., Bernstein, A., Thirumavalavan, N., & Ramasamy, R. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00890-x · Cited by 12
Kurniawan, A. L., Hsu, C., Chao, J. C.-J., Paramastri, R., Lee, H.-A., Lai, P.-C., Hsieh, N., & Wu, S. V. (2021) · Nutrients · doi:10.3390/nu13010259 · Cited by 12
Injection testosterone and adverse cardiovascular events: A case‐crossover analysis
Layton, J. B., Li, D., Meier, C. R., Sharpless, J. L., Stürmer, T., & Brookhart, M. A. (2018) · Clinical Endocrinology · doi:10.1111/cen.13574 · Cited by 11
Swerdloff, R. S., & Wang, C. (2020) · Andrology · doi:10.1111/andr.12901 · Cited by 11
Self-citationLate-Onset Hypogonadism as Primary Testicular Failure
Swee, D. S., & Gan, E. H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00372 · Cited by 11
Anawalt, B. D., O’Connor, K., & Grossmann, M. (2026) · JAMA · doi:10.1001/jama.2026.8526 · Cited by 11
Pan, J., Zheng, Z., Mao, X., Hu, D., Wang, W., Liao, G., & Hao, Z. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.230110 · Cited by 10
Zheng, Z., Pan, J., Liu, M., Chen, Z., Zhang, L., Gao, J., Gao, P., & Zhang, X. (2024) · The Aging Male · doi:10.1080/13685538.2024.2346312 · Cited by 10
Testosterone Replacement Reduces Morbidity and Mortality for Most Patients With Cirrhosis
Tapper, E. B., Chen, X., & Parikh, N. D. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.02.004 · Cited by 10
Braga, M. A. P., Rivera, A., Marinheiro, G., Felix, N. S., Carvalho, P. E. P., Gewehr, D. M., Teixeira, L., Clemente, M. R. C., Reis, P. C. A., de Amorim, L. G. C. R., et al. (2025) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-025-00737-w · Cited by 10
Metadata
- Authors
- Roy, C. N., Snyder, P. J., Stephens-Shields, A. J., Artz, A. S., Bhasin, S., Cohen, H. J., Farrar, J. T., Gill, T. M., Zeldow, B., Cella, D., Barrett-Connor, E., Cauley, J. A., Crandall, J. P., Cunningham, G. R., Ensrud, K. E., Lewis, C. E., Matsumoto, A. M., Molitch, M. E., Pahor, M., Swerdloff, R. S., Cifelli, D., Hou, X., Resnick, S. M., Walston, J. D., Anton, S., Basaria, S., Diem, S. J., Wang, C., Schrier, S. L., & Ellenberg, S. S.
- Affiliations
- Johns Hopkins University (US)
- University of Pennsylvania (US)
- Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
- University of Chicago (US)
- Brigham and Women's Hospital (US)
- Duke Medical Center (US)
- Yale University (US)
- Northwestern University (US)
- University of California San Diego (US)
- University of Pittsburgh (US)
- Albert Einstein College of Medicine (US)
- Baylor College of Medicine (US)
- University of Minnesota (US)
- University of Alabama at Birmingham (US)
- University of Washington (US)
- University of Florida (US)
- University of California, Los Angeles (US)
- National Institutes of Health (US)
- Stanford Medicine (US)
- Corresponding author
- Snyder, Peter J.
- ORCID
- Snyder, Peter J.
- Artz, Andrew S.
- Bhasin, Shalender
- Cohen, Harvey J.
- Farrar, John T.
- Gill, Thomas M.
- Zeldow, Bret
- Cella, David
- Barrett-Connor, Elizabeth
- Cauley, Jane A.
- Crandall, Jill P.
- Cunningham, Glenn R.
- Ensrud, Kristine E.
- Lewis, Cora E.
- Matsumoto, Alvin M.
- Molitch, Mark E.
- Swerdloff, Ronald S.
- Hou, Xiaoling
- Resnick, Susan M.
- Walston, Jeremy D.
- Anton, Stephen
- Basaria, Shehzad
- Diem, Susan J.
- Wang, Christina
- Ellenberg, Susan S.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2017-04-01
- Volume
- 177
- Issue
- 4
- Pages
- 480
- ISSN
- 2168-6106 (ISSN-L)
- PMC
- PMC5433757
- OpenAlex
- W2593639365
- Cited by
- 239
- References
- 44
- Citations by year
- 2026: 8 · 2025: 24 · 2024: 24 · 2023: 17 · 2022: 31 · 2021: 25 · 2020: 22 · 2019: 33 · 2018: 34 · 2017: 21
- FWCI
- 23.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p30ag031679-15, UL1TR001863)
- National Institute on Aging (U01AG030644, K07AG043587, P30-AG031679, U01AG034661, P30AG028740, P30AG021342)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK060455, P30DK020541)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- testosterone replacement therapy, testosterone gel, anemia, older men, androgen deficiency, hemoglobin, anemia of chronic disease, cancer-related anemia
- MeSH terms
- Aged, Androgens, Anemia, Double-Blind Method, Drug Administration Routes, Hemoglobins, Humans, Male, Testosterone, Treatment Outcome, Drug Monitoring, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review